Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
Canada https://nrc.canada.ca/en/stories/quest-vaccine-nrc-researchers-mobilize-advance-technologies-against-covid-19 National Research Council of Canada supports development of 4 COVID-19 therapeutic
-
generation of vaccine researchers. This will be achieved by funding trainees working on projects funded by CIRN, projects that support CIRN networks, and projects funded outside of CIRN that support CIRN’s
-
The $150,000 Michelson Prizes are awarded annually to support early-career investigators working to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases
-
human immunology, with trans disease applications to accelerate vaccine and immunotherapeutic discovery. Through a partnership with AAAS/Science, Michelson Philanthropies supports young investigators from
-
permanent, GMP-compliant clinical trial material facility at its Royalmount Avenue site in Montréal. When complete, this facility will be used to manufacture vaccine and other biologic materials for clinical
-
permanent, Good Manufacturing Pratice (GMP) compliant clinical trial material facility at its Royalmount Avenue site in Montréal. This facility will be used to manufacture vaccine and other biologic materials
-
evolving RNA viruses Athanasios Kritharis Doctor of Philosophy in Chemical and Biological Engineering (PhD) A new technological paradigm for low-cost, decentralized vaccine manufacture Baraa Orabi Doctor
-
health Athanasios Kritharis Doctor of Philosophy in Chemical and Biological Engineering (PhD) A new technological paradigm for low-cost, decentralized vaccine manufacture View All Stories Further
-
goes viral? Investigating the Coalition for Epidemic Preparedness and Innovation’s novel strategies for mending vaccine markets and preventing emerging infectious disease outbreak Vasileia Karasavva